2025年2月4日 · Eprex 40000 IU/ml solution for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

EPREX is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion. EPREX can reduce the need for a blood transfusion in these patients.

2025年1月30日 · Eprex 10000 IU/ml solution for injection in pre-filled syringe - Patient Information Leaflet (PIL) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

When you have erythropoietin injections, the amount of the protein in your body becomes much higher than normal. This may cause side effects, but these are usually mild or moderate. We explain the most common side effects of this treatment here. …

Patient information for EPREX 4 000 IU/ML SOLUTION FOR INJECTION IN PFS Including dosage instructions and possible side effects.

EPREX is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion. EPREX can reduce the need for a blood transfusion in these patients.

Pure red cell aplasia following erythropoietin therapy; uncontrolled hypertension

Actual Medicinal Product (AMP) - Eprex 2,000units/0.5ml solution for injection pre-filled syringes (Janssen-Cilag Ltd)

Show Eprex 6,000units/0.6ml solution for injection pre-filled syringes Janssen-Cilag Ltd

2014年11月26日 · Evidence-based recommendations on erythropoiesis-stimulating agents (epoetin alfa [Eprex], epoetin beta [NeoRecormon], epoetin theta, epoeitin zeta [Retacrit] and darbepoetin alfa [Aranesp]) for treating anaemia in adults with cancer having chemotherapy